Compounds > 2-naphthol
Page last updated: 2024-08-18

2-naphthol and way 202196

2-naphthol has been researched along with way 202196 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edsall, RJ; Harris, HA; Henderson, RA; Keith, JC; Manas, ES; Mewshaw, RE; Xu, ZB; Yang, C1
Cristofaro, PA; Harris, HA; Jhung, J; Keith, JC; Opal, SM; Palardy, JE; Parejo, NA1
Crabtree, JS; Harris, HA; Peano, BJ; Winneker, RC; Zhang, X; Zhang, Z1
Dalziel, C; Turner, B1
Christaki, E; Harris, HA; Keith, JC; Kessinian, N; Lavallie, E; Malamas, MS; Mewshaw, RE; Mounts, W; Opal, SM; Palardy, JE; Parejo, NA; Racie, L; Vlasuk, GP1

Other Studies

5 other study(ies) available for 2-naphthol and way 202196

ArticleYear
ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
    Journal of medicinal chemistry, 2005, Jun-16, Volume: 48, Issue:12

    Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Estrogen Receptor beta; Female; Genistein; Humans; Inflammatory Bowel Diseases; Ligands; Male; Models, Molecular; Molecular Conformation; Molecular Mimicry; Molecular Structure; Naphthalenes; Naphthols; Organ Size; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Transcription, Genetic; Uterus

2005
WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock.
    Critical care medicine, 2006, Volume: 34, Issue:8

    Topics: Administration, Oral; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Estrogen Receptor beta; Female; Interleukin-6; Intestinal Mucosa; Listeria monocytogenes; Male; Mice; Mice, Inbred BALB C; Naphthols; Neutropenia; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha

2006
Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.
    The Journal of steroid biochemistry and molecular biology, 2006, Volume: 101, Issue:1

    Topics: Animals; Base Sequence; Benzoxazines; DNA Primers; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Mammary Glands, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Models, Animal; Naphthols; Oligonucleotide Array Sequence Analysis; Oxazoles; Phenols; Progesterone; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Thiones; Uterus

2006
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:11

    Topics: Animals; Anti-Infective Agents; Carbapenems; Cephalosporins; Drugs, Investigational; Estrogen Receptor Modulators; Fluoroquinolones; Humans; Naphthols; Societies, Scientific; United States

2006
Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study.
    The Journal of infectious diseases, 2010, Apr-15, Volume: 201, Issue:8

    Topics: Animals; Disease Models, Animal; Estrogen Receptor beta; Female; Gene Expression Profiling; Male; Mice; Mice, Inbred BALB C; Naphthols; Oxazoles; Pneumonia, Pneumococcal; Sepsis; Transcription, Genetic

2010